GO:0062100 positive regulation of programmed necrotic cell death: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0062100 describes any process that increases the frequency, rate or extent of programmed necrotic cell death, a genetically controlled form of necrosis distinct from accidental necrosis.
• Programmed necrotic cell death includes regulated forms such as ferroptosis, pyroptosis, and necroptosis, each with dedicated molecular machinery.
• Key positive regulators include VDAC1 oligomerization in ferroptosis, NLRP3/caspase-1/GSDMD and caspase-3/GSDME pathways in pyroptosis, and lipid lipotoxicity in metabolic stress.
• Dysregulation of programmed necrotic cell death contributes to cancer progression, ischemia-reperfusion injury, neurodegeneration, and inflammatory diseases.
• CRISPR knockout, point mutation, knock-in, and overexpression models are essential to dissect causal roles of specific genes in this process.
• EDITGENE provides end-to-end CRISPR services including KO, point mutation, knock-in, overexpression, library screening, and bioinformatics to accelerate programmed necrotic cell death research.
Description
Programmed necrotic cell death is a genetically encoded process that leads to necrotic morphology, contrasting with accidental necrosis. GO:0062100, positive regulation of programmed necrotic cell death, encompasses any molecular event that increases the frequency, rate, or extent of this form of cell death. This term is critical for understanding how cells actively execute necrosis under physiological and pathological conditions, including development, immunity, and tissue homeostasis. Research has identified multiple regulated necrotic death modalities, such as ferroptosis, pyroptosis, and necroptosis, each with distinct positive regulators. For example, ferroptosis is an autophagic cell death process driven by iron-dependent lipid peroxidation, while pyroptosis involves inflammasome-mediated activation of gasdermin proteins. These pathways are positively regulated by specific genes and signaling cascades that are attractive therapeutic targets. Understanding GO:0062100 is therefore essential for researchers studying cell death mechanisms, disease pathogenesis, and potential interventions.
positive regulation of programmed necrotic cell death At A Glance
| GO ID | GO:0062100 |
|---|---|
| GO term | positive regulation of programmed necrotic cell death |
| Ontology | biological_process |
| Synonym | none |
| Major function | Upregulation of genetically controlled necrotic cell death pathways |
| Related processes | Ferroptosis, pyroptosis, necroptosis, mitochondrial permeability transition |
| Key regulators | VDAC1, NLRP3, caspase-1, GSDMD, GSDME, HDAC11, VSTM2L |
| Disease relevance | Cancer, ischemia-reperfusion injury, neurodegeneration, inflammatory diseases |
What Is GO:0062100?
GO:0062100 is defined as any biological process that increases the frequency, rate, or extent of programmed necrotic cell death. In other words, it covers the positive regulatory inputs—molecular signals, protein modifications, and pathway activations—that promote a genetically controlled form of necrosis. This term is a child of 'positive regulation of programmed cell death' and is distinct from passive, accidental necrosis.
Why Is positive regulation of programmed necrotic cell death Important in Cell Biology?
Positive regulation of programmed necrotic cell death is important because it governs whether cells undergo a controlled necrotic demise in response to stress, infection, or developmental cues. This process is critical for eliminating damaged or infected cells, shaping immune responses, and maintaining tissue homeostasis. Dysregulation can lead to pathology: excessive programmed necrosis contributes to ischemia-reperfusion injury and neurodegeneration, while insufficient activation may promote tumorigenesis and immune evasion. Moreover, modulating these pathways offers therapeutic opportunities, such as inducing ferroptosis in cancer cells or inhibiting pyroptosis in inflammatory diseases.
• Controls a genetically defined form of cell death distinct from apoptosis and accidental necrosis.
• Plays a key role in development, immune defense, and tissue remodeling.
• Ferroptosis, a major programmed necrotic modality, is positively regulated by VDAC1 oligomerization and inhibited by VSTM2L.
• Pyroptosis is positively regulated through NLRP3/caspase-1/GSDMD and caspase-3/GSDME pathways, with HDAC11 as a positive regulator.
• Lipid storage and lipotoxicity in obesity can promote programmed necrotic cell death.
• Dysregulation is linked to cancer, cardiovascular disease, neurodegeneration, and inflammatory conditions.
• Targeting positive regulators offers therapeutic strategies for cancer, ischemia-reperfusion injury, and autoimmunity.
• Understanding positive regulation aids in identifying biomarkers and drug targets.
• CRISPR-based models enable precise dissection of causal roles of specific genes.
• Bioinformatics and screening approaches can uncover novel regulators within this GO term.
What Happens During positive regulation of programmed necrotic cell death?
Initiation by death-inducing signals
In simple terms: Certain stress signals turn on a self-destruct program that leads to necrosis.
Positive regulation begins when specific stimuli—such as oxidative stress, lipid peroxidation, or inflammatory cytokines—activate dedicated signaling cascades. For example, in ferroptosis, iron-dependent lipid peroxidation triggers a chain reaction that promotes cell death. In pyroptosis, inflammasome activation leads to caspase-1 cleavage and gasdermin D pore formation. These initiating events are positively regulated by upstream sensors and effectors that amplify the death signal.
Amplification through positive feedback loops
In simple terms: The death signal gets stronger through feedback loops that keep the process going.
Once initiated, programmed necrotic cell death is often amplified by positive feedback mechanisms. For instance, mitochondrial dysfunction and reactive oxygen species (ROS) production can further promote lipid peroxidation and ferroptosis. In pyroptosis, gasdermin pores facilitate the release of inflammatory mediators that recruit more cells and enhance the response. These amplification loops ensure that the death program proceeds efficiently once triggered.
Execution by pore-forming proteins and organelle damage
In simple terms: Proteins punch holes in membranes and damage organelles, leading to cell rupture.
The execution phase involves pore-forming proteins such as GSDMD and GSDME, which permeabilize the plasma membrane and cause osmotic lysis. In ferroptosis, excessive lipid peroxidation compromises membrane integrity and leads to mitochondrial dysfunction. These events are positively regulated by factors that enhance pore formation or inhibit membrane repair mechanisms.
Inflammatory and immune consequences
In simple terms: The dying cell releases signals that alert the immune system.
Programmed necrotic cell death is inherently immunogenic, releasing damage-associated molecular patterns (DAMPs) and cytokines. This can enhance anti-tumor immunity or exacerbate inflammatory diseases. Positive regulation of this process thus influences the balance between immune activation and tissue damage.
Key Genes Involved in GO:0062100 positive regulation of programmed necrotic cell death
The following genes and proteins are key positive regulators or mediators of programmed necrotic cell death, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| VDAC1 | Oligomerization promotes mitochondrial permeability and ferroptosis | Target for ferroptosis induction in cancer |
| VSTM2L | Inhibits VDAC1 oligomerization, protecting against ferroptosis | Negative regulator; potential therapeutic target |
| NLRP3 | Inflammasome sensor that activates caspase-1 | Central to pyroptosis; drug target |
| CASP1 | Cleaves GSDMD to induce pyroptosis | Key effector of inflammatory cell death |
| GSDMD | Pore-forming protein in pyroptosis | Executioner of pyroptosis |
| GSDME | Pore-forming protein activated by caspase-3 | Mediates pyroptosis in various contexts |
| HDAC11 | Promotes NLRP3/caspase-1/GSDMD and caspase-3/GSDME pathways | Positive regulator of pyroptosis |
| ERG | Transcription factor mediating HDAC11 effects | Downstream effector in pyroptosis |
| CASP3 | Cleaves GSDME to trigger pyroptosis | Links apoptosis to pyroptosis |
| GPX4 | Glutathione peroxidase that detoxifies lipid peroxides | Negative regulator of ferroptosis |
| SLC7A11 | Cystine/glutamate antiporter supporting glutathione synthesis | Inhibits ferroptosis |
| ACSL4 | Promotes lipid peroxidation | Positive regulator of ferroptosis |
| RIPK1 | Kinase in necroptosis signaling | Positive regulator of necroptosis |
| RIPK3 | Kinase that activates MLKL | Positive regulator of necroptosis |
| MLKL | Pore-forming protein in necroptosis | Executioner of necroptosis |
| TNF | Cytokine that can induce necroptosis | Upstream inducer |
| CXCL13 | Chemokine involved in immune cell recruitment | Associated with tertiary lymphoid structures and cell death |
How Is positive regulation of programmed necrotic cell death Regulated?
Programmed necrotic cell death is tightly regulated at multiple levels. Positive regulation can occur through transcriptional upregulation of pro-necrotic genes, post-translational modifications such as phosphorylation or ubiquitination, and metabolic shifts that increase lipid peroxidation or ROS. For example, HDAC11 promotes pyroptosis by modulating ERG expression, while VSTM2L inhibits ferroptosis by blocking VDAC1 oligomerization. Additionally, lipid storage and lipolysis in obesity can influence lipotoxicity and programmed necrosis. These regulatory layers provide numerous entry points for therapeutic intervention.
positive regulation of programmed necrotic cell death and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| VDAC1 | Cancer (ferroptosis evasion) | KO and overexpression in cancer cell lines |
| NLRP3 | Inflammatory diseases (pyroptosis) | KO mice and point mutations in macrophages |
| GSDMD | Sepsis, inflammatory bowel disease | Knock-in of pore-forming mutants |
| GPX4 | Neurodegeneration, cancer | Conditional KO in neurons |
| RIPK3 | Ischemia-reperfusion injury | Kinase-dead knock-in mice |
Cancer
Programmed necrotic cell death can be either tumor-suppressive or tumor-promoting depending on context. Ferroptosis induction is a promising strategy to kill therapy-resistant cancer cells, and positive regulators such as VDAC1 are targets for activation. Conversely, some cancers evade programmed necrosis by upregulating inhibitors like VSTM2L. Understanding positive regulation helps design drugs that tip the balance toward cell death.
Inflammatory and infectious diseases
Pyroptosis is a major programmed necrotic pathway that releases inflammatory cytokines and DAMPs. Excessive pyroptosis contributes to sepsis, inflammatory bowel disease, and atherosclerosis. Positive regulators like NLRP3, caspase-1, and GSDMD are therapeutic targets for anti-inflammatory strategies.
Metabolic and obesity-related disorders
Lipid storage, lipolysis, and lipotoxicity in obesity can promote programmed necrotic cell death in various tissues, contributing to insulin resistance and organ damage. Modulating these pathways may offer benefits in metabolic diseases.
Neurodegeneration and ischemia
Programmed necrotic cell death, including ferroptosis and necroptosis, is implicated in neuronal loss after ischemia-reperfusion injury and in neurodegenerative diseases. Positive regulators such as RIPK1/RIPK3/MLKL are being explored as targets for neuroprotection.
From positive regulation of programmed necrotic cell death-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X positively regulate ferroptosis? | CRISPR KO and overexpression in cancer cells |
| What is the role of a specific phosphorylation site in pyroptosis? | Point mutation knock-in |
| How does a disease-associated mutation affect programmed necrosis? | Knock-in of mutant allele |
| Can a tagged protein track necrotic death in live cells? | Tagged knock-in (e.g., GFP) |
| Does overexpression of a candidate gene enhance necroptosis? | Overexpression cell lines |
| Which genes are essential for programmed necrosis in a genome-wide screen? | CRISPR library screening |
How to Study the positive regulation of programmed necrotic cell death Process
| Method | What It Measures | Typical Application |
|---|---|---|
| CRISPR KO screening | Loss-of-function effects on cell death | Identify positive regulators |
| Overexpression | Gain-of-function effects | Confirm sufficiency of a gene |
| Point mutation knock-in | Effect of specific amino acid changes | Dissect catalytic or modification sites |
| Live-cell imaging | Real-time cell death dynamics | Monitor pore formation and lipid peroxidation |
| Western blot | Protein cleavage and activation | Detect caspase-1, GSDMD, MLKL |
| Lipid peroxidation assay | Oxidative damage to lipids | Quantify ferroptosis |
| RNA-seq | Transcriptional changes | Identify pathways and regulators |
| Proteomics | Protein abundance and modifications | Discover novel regulators |
CRISPR-based genetic screens
Genome-wide CRISPR knockout or activation screens can identify positive regulators of programmed necrotic cell death. For example, screens for ferroptosis regulators have uncovered VDAC1 and other genes. These unbiased approaches are powerful for discovering novel components of GO:0062100.
Live-cell imaging and reporters
Fluorescent reporters for lipid peroxidation, membrane integrity, or gasdermin pore formation allow real-time monitoring of programmed necrosis. Imaging can reveal the kinetics and subcellular localization of positive regulators.
Biochemical assays for pathway activation
Western blotting for cleaved caspase-1, GSDMD, or MLKL phosphorylation, along with lipid peroxidation assays, quantifies pathway activation. These methods are standard for validating positive regulators.
Transcriptomics and proteomics
RNA-seq and proteomics can identify gene expression changes and post-translational modifications that accompany programmed necrotic cell death. Such data help map the regulatory network of GO:0062100.
How CRISPR Can Be Used to Study GO:0062100 positive regulation of programmed necrotic cell death
Knockout
CRISPR knockout of candidate positive regulators (e.g., VDAC1, NLRP3) can abolish programmed necrotic cell death, confirming their essential role. For example, VDAC1 knockout reduces ferroptosis, and NLRP3 knockout impairs pyroptosis.
Point Mutation
Introducing precise point mutations (e.g., in GSDMD or MLKL) can test the importance of specific residues for pore formation or activation. Such models are invaluable for mechanistic studies.
Knock-in
Knock-in of tagged or mutant alleles (e.g., GFP-tagged MLKL) allows tracking of protein localization and dynamics during programmed necrosis. Disease-associated mutations can also be knocked in to study pathogenesis.
Overexpression
Overexpression of positive regulators (e.g., RIPK3, ACSL4) can sensitize cells to programmed necrotic death, demonstrating sufficiency. This approach is useful for gain-of-function studies.
How EDITGENE Supports positive regulation of programmed necrotic cell death Research
Researchers studying positive regulation of programmed necrotic cell death-related genes often need to determine whether a candidate gene is causally involved in promoting or inhibiting this process. EDITGENE provides a comprehensive suite of CRISPR services to enable such investigations with high precision and efficiency.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of programmed necrotic cell death research.
Frequently Asked Questions About positive regulation of programmed necrotic cell death
What is GO:0062100?
GO:0062100 is a Gene Ontology term for 'positive regulation of programmed necrotic cell death', describing any process that increases the frequency, rate, or extent of genetically controlled necrotic cell death.
What genes are involved in positive regulation of programmed necrotic cell death?
Key genes include VDAC1, NLRP3, CASP1, GSDMD, GSDME, HDAC11, RIPK1, RIPK3, MLKL, and ACSL4, among others.
How does ferroptosis relate to programmed necrotic cell death?
Ferroptosis is a form of programmed necrotic cell death driven by iron-dependent lipid peroxidation, positively regulated by VDAC1 and inhibited by VSTM2L.
What is the role of pyroptosis in programmed necrosis?
Pyroptosis is a programmed necrotic pathway mediated by gasdermin pores, positively regulated by NLRP3/caspase-1/GSDMD and caspase-3/GSDME signaling.
Which diseases are associated with dysregulated programmed necrotic cell death?
Cancer, inflammatory diseases, ischemia-reperfusion injury, neurodegeneration, and metabolic disorders are linked to altered programmed necrosis.
How can CRISPR be used to study programmed necrotic cell death?
CRISPR knockout, point mutation, knock-in, and overexpression models allow precise dissection of gene function in programmed necrosis.
What methods are used to measure programmed necrotic cell death?
Common methods include live-cell imaging, Western blot for cleaved caspases or MLKL, lipid peroxidation assays, and CRISPR screens.
What is the difference between apoptosis and programmed necrosis?
Apoptosis is caspase-dependent and non-immunogenic, while programmed necrosis involves pore-forming proteins, is immunogenic, and leads to lytic cell death.
Can programmed necrotic cell death be inhibited therapeutically?
Yes, inhibitors of NLRP3, caspase-1, or RIPK1 are being explored for inflammatory and neurodegenerative diseases.
What services does EDITGENE offer for programmed necrotic cell death research?
EDITGENE provides CRISPR KO, point mutation, knock-in, overexpression, library screening, and bioinformatics services to study this process.
Conclusion
GO:0062100, positive regulation of programmed necrotic cell death, is a critical biological process with broad implications for health and disease. Understanding its molecular players and regulatory mechanisms can reveal new therapeutic targets for cancer, inflammation, and neurodegeneration. EDITGENE's CRISPR services empower researchers to dissect these pathways with precision and speed.
References
- 1. Yang J et al.. 2025. VSTM2L protects prostate cancer cells against ferroptosis via inhibiting VDAC1 oligomerization and maintaining mitochondria homeostasis.. Nat Commun 16(1):1160 PMID: 39880844
- 2. Engin A. 2024. Lipid Storage, Lipolysis, and Lipotoxicity in Obesity.. Adv Exp Med Biol 1460:97-129 PMID: 39287850
- 3. Gao M et al.. 2016. Ferroptosis is an autophagic cell death process.. Cell Res 26(9):1021-32 PMID: 27514700
- 4. Hu C et al.. 2024. Tertiary Lymphoid Structure-Associated B Cells Enhance CXCL13(+)CD103(+)CD8(+) Tissue-Resident Memory T-Cell Response to Programmed Cell Death Protein 1 Blockade in Cancer Immunotherapy.. Gastroenterology 166(6):1069-1084 PMID: 38445519
- 5. Wang B et al.. 2025. Multiple cell death modalities and immune response in pulpitis.. Int Endod J 58(1):111-127 PMID: 39257034
- 7. Yao F et al.. 2022. HDAC11 promotes both NLRP3/caspase-1/GSDMD and caspase-3/GSDME pathways causing pyroptosis via ERG in vascular endothelial cells.. Cell Death Discov 8(1):112 PMID: 35279683
- 8. Tower J. 2015. Programmed cell death in aging.. Ageing Res Rev 23(Pt A):90-100 PMID: 25862945
